Therefore, we analyzed the RNA-expression of BMP-2 in a panel of BRAF mutated patient-derived melanoma cells (therapy-naïve and during targeted therapy using BRAF and/or MEK inhibitors) from the publically available Zurich biobank database (http://tcgabrowser.ethz.ch:3839/MCE/). This evidence concerns the gene BMP2 and melanoma.